Vasopressin, prolactin and growth hormone in Alzheimer's disease: their evaluation after metoclopramide stimulation
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 10 (3) , 269-278
- https://doi.org/10.1016/0167-4943(90)90028-5
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Growth hormone, 1988.Journal of Clinical Investigation, 1988
- Alterations in vasopressin regulation in Alzheimer's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- Risk factors for clinically diagnosed patients of Alzheimer??s disease: A case-control study of an Italian populationAlzheimer Disease & Associated Disorders, 1987
- Role of Aging on Growth Hormone and Prolactin Release after Growth Hormone-Releasing Hormone and Domperidone in ManHormone Research, 1987
- Vasopressin in Alzheimer's disease: A study of postmortem brain concentrationsAnnals of Neurology, 1986
- Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatinJournal of Endocrinology, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Reduced lumbar CSF somatostatin in levels in Alzheimer's diseaseLife Sciences, 1982
- MetoclopramideNew England Journal of Medicine, 1981
- DOPAMINE IN ALZHEIMER'S DISEASE AND SENILE DEMENTIAThe Lancet, 1979